Annual report
7730.TEDINET S100PO97
Period2021-09-01 → 2022-08-31
Filed2022-11-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥20.4bn | 2021-09-01 → 2022-08-31 | Cons. | Net sales |
| Revenue | ¥17.2bn | 2020-09-01 → 2021-08-31 | Cons. | Net sales |
| Revenue | ¥15.2bn | 2019-09-01 → 2020-08-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥18.3bn | 2018-09-01 → 2019-08-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥20.1bn | 2017-09-01 → 2018-08-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥6.2bn | 2021-09-01 → 2022-08-31 | Cons. | Operating income |
| Operating income | ¥5.3bn | 2020-09-01 → 2021-08-31 | Cons. | Operating income |
| Ordinary income | ¥7.5bn | 2021-09-01 → 2022-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥5.7bn | 2020-09-01 → 2021-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥4.4bn | 2019-09-01 → 2020-08-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.7bn | 2018-09-01 → 2019-08-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.2bn | 2017-09-01 → 2018-08-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥7.4bn | 2021-09-01 → 2022-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥6.0bn | 2020-09-01 → 2021-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥5.3bn | 2021-09-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.3bn | 2020-09-01 → 2021-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.3bn | 2019-09-01 → 2020-08-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥6.1bn | 2018-09-01 → 2019-08-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.8bn | 2017-09-01 → 2018-08-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥5.3bn | 2021-09-01 → 2022-08-31 | Cons. | Profit loss |
| Net income | ¥4.3bn | 2020-09-01 → 2021-08-31 | Cons. | Profit loss |
| Total assets | ¥50.1bn | at 2022-08-31 | Cons. | Assets |
| Total assets | ¥42.7bn | at 2021-08-31 | Cons. | Assets |
| Total assets | ¥39.3bn | at 2020-08-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥39.8bn | at 2019-08-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥37.7bn | at 2018-08-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.7bn | at 2022-08-31 | Cons. | Liabilities |
| Total liabilities | ¥3.5bn | at 2021-08-31 | Cons. | Liabilities |
| Net assets / equity | ¥45.4bn | at 2022-08-31 | Cons. | Net assets |
| Net assets / equity | ¥39.2bn | at 2021-08-31 | Cons. | Net assets |
| Net assets / equity | ¥36.6bn | at 2020-08-31d | Cons. | Net assets |
| Net assets / equity | ¥35.3bn | at 2019-08-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥33.5bn | at 2018-08-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥22.7bn | at 2022-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥18.3bn | at 2021-08-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥22.1bn | at 2022-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.1bn | at 2021-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥17.0bn | at 2020-08-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥16.1bn | at 2019-08-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥12.0bn | at 2018-08-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥6.6bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥6.4bn | 2020-09-01 → 2021-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.9bn | 2019-09-01 → 2020-08-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.3bn | 2018-09-01 → 2019-08-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.6bn | 2017-09-01 → 2018-08-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.2bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.4bn | 2020-09-01 → 2021-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥38m | 2019-09-01 → 2020-08-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥810m | 2018-09-01 → 2019-08-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥144m | 2017-09-01 → 2018-08-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥2.4bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.2bn | 2020-09-01 → 2021-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.1bn | 2019-09-01 → 2020-08-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.8bn | 2018-09-01 → 2019-08-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.1bn | 2017-09-01 → 2018-08-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥53.75 | 2021-09-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.6 | 2020-09-01 → 2021-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.83 | 2019-09-01 → 2020-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.99 | 2018-09-01 → 2019-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.31 | 2017-09-01 → 2018-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥461.41 | at 2022-08-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥398.29 | at 2021-08-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥371.51 | at 2020-08-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥358.92 | at 2019-08-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥340.83 | at 2018-08-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 90.6% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.8% | at 2021-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.1% | at 2020-08-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.7% | at 2019-08-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.0% | at 2018-08-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 12.5% | 2021-09-01 → 2022-08-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.3% | 2020-09-01 → 2021-08-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.3% | 2019-09-01 → 2020-08-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.7% | 2018-09-01 → 2019-08-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.8% | 2017-09-01 → 2018-08-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 3,417 | at 2022-08-31 | Cons. | Number of employees |
| Employees | 3,313 | at 2021-08-31 | Cons. | Number of employees |
| Employees | 3,812 | at 2020-08-31d | Cons. | Number of employees |
| Employees | 3,810 | at 2019-08-31d | Cons. | Number of employees |
| Employees | 3,653 | at 2018-08-31d | Cons. | Number of employees |
| Revenue | ¥17.6bn | 2021-09-01 → 2022-08-31 | Standalone | Net sales |
| Revenue | ¥14.8bn | 2020-09-01 → 2021-08-31 | Standalone | Net sales |
| Revenue | ¥13.8bn | 2019-09-01 → 2020-08-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥16.6bn | 2018-09-01 → 2019-08-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥15.6bn | 2017-09-01 → 2018-08-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥4.2bn | 2021-09-01 → 2022-08-31 | Standalone | Operating income |
| Operating income | ¥4.3bn | 2020-09-01 → 2021-08-31 | Standalone | Operating income |
| Ordinary income | ¥7.5bn | 2021-09-01 → 2022-08-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.7bn | 2020-09-01 → 2021-08-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.2bn | 2019-09-01 → 2020-08-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.5bn | 2018-09-01 → 2019-08-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.4bn | 2017-09-01 → 2018-08-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥7.4bn | 2021-09-01 → 2022-08-31 | Standalone | Income before income taxes |
| Profit before tax | ¥4.8bn | 2020-09-01 → 2021-08-31 | Standalone | Income before income taxes |
| Net income | ¥5.5bn | 2021-09-01 → 2022-08-31 | Standalone | Profit loss |
| Net income | ¥3.4bn | 2020-09-01 → 2021-08-31 | Standalone | Profit loss |
| Net income | ¥3.4bn | 2019-09-01 → 2020-08-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥5.2bn | 2018-09-01 → 2019-08-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥3.4bn | 2017-09-01 → 2018-08-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥41.3bn | at 2022-08-31 | Standalone | Assets |
| Total assets | ¥37.2bn | at 2021-08-31 | Standalone | Assets |
| Total assets | ¥35.3bn | at 2020-08-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥36.1bn | at 2019-08-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥34.5bn | at 2018-08-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.8bn | at 2022-08-31 | Standalone | Liabilities |
| Total liabilities | ¥2.8bn | at 2021-08-31 | Standalone | Liabilities |
| Net assets / equity | ¥37.5bn | at 2022-08-31 | Standalone | Net assets |
| Net assets / equity | ¥34.4bn | at 2021-08-31 | Standalone | Net assets |
| Net assets / equity | ¥33.2bn | at 2020-08-31d | Standalone | Net assets |
| Net assets / equity | ¥32.2bn | at 2019-08-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥30.9bn | at 2018-08-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥15.2bn | at 2022-08-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥12.7bn | at 2021-08-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥55.9 | 2021-09-01 → 2022-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.98 | 2020-09-01 → 2021-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.31 | 2019-09-01 → 2020-08-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.59 | 2018-09-01 → 2019-08-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.74 | 2017-09-01 → 2018-08-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥30 | 2021-09-01 → 2022-08-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥23 | 2020-09-01 → 2021-08-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥22 | 2019-09-01 → 2020-08-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2018-09-01 → 2019-08-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥42 | 2017-09-01 → 2018-08-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥381.33 | at 2022-08-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥349.63 | at 2021-08-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥337.38 | at 2020-08-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥327.15 | at 2019-08-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥314.05 | at 2018-08-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 90.9% | at 2022-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.4% | at 2021-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.1% | at 2020-08-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.2% | at 2019-08-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.5% | at 2018-08-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 15.3% | 2021-09-01 → 2022-08-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.2% | 2020-09-01 → 2021-08-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.3% | 2019-09-01 → 2020-08-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.4% | 2018-09-01 → 2019-08-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.6% | 2017-09-01 → 2018-08-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 106,911,000 | at 2022-08-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 106,911,000 | at 2021-08-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 106,911,000 | at 2020-08-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,637,000 | at 2019-08-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,637,000 | at 2018-08-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 350 | at 2022-08-31 | Standalone | Number of employees |
| Employees | 333 | at 2021-08-31 | Standalone | Number of employees |
| Employees | 320 | at 2020-08-31d | Standalone | Number of employees |
| Employees | 315 | at 2019-08-31d | Standalone | Number of employees |
| Employees | 302 | at 2018-08-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2021-09-01 → 2022-08-31 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-09-01 → 2022-08-31 | −¥2m |
| Dental Related Productsreportable segment | depreciation | 2021-09-01 → 2022-08-31 | ¥695m |
| Dental Related Productsreportable segment | employees | at 2022-08-31 | 1207 pure |
| Dental Related Productsreportable segment | revenue | 2021-09-01 → 2022-08-31 | ¥8.2bn |
| Dental Related Productsreportable segment | revenue external | 2021-09-01 → 2022-08-31 | ¥8.2bn |
| Dental Related Productsreportable segment | segment profit | 2021-09-01 → 2022-08-31 | ¥2.4bn |
| Eyeless Needle Related Productsreportable segment | depreciation | 2021-09-01 → 2022-08-31 | ¥617m |
| Eyeless Needle Related Productsreportable segment | employees | at 2022-08-31 | 1233 pure |
| Eyeless Needle Related Productsreportable segment | revenue | 2021-09-01 → 2022-08-31 | ¥6.3bn |
| Eyeless Needle Related Productsreportable segment | revenue external | 2021-09-01 → 2022-08-31 | ¥6.3bn |
| Eyeless Needle Related Productsreportable segment | revenue intersegment | 2021-09-01 → 2022-08-31 | ¥2m |
| Eyeless Needle Related Productsreportable segment | segment profit | 2021-09-01 → 2022-08-31 | ¥1.8bn |
| Surgel Related Productsreportable segment | depreciation | 2021-09-01 → 2022-08-31 | ¥356m |
| Surgel Related Productsreportable segment | employees | at 2022-08-31 | 553 pure |
| Surgel Related Productsreportable segment | revenue | 2021-09-01 → 2022-08-31 | ¥6.0bn |
| Surgel Related Productsreportable segment | revenue external | 2021-09-01 → 2022-08-31 | ¥6.0bn |
| Surgel Related Productsreportable segment | segment profit | 2021-09-01 → 2022-08-31 | ¥2.0bn |
| —segment total | depreciation | 2021-09-01 → 2022-08-31 | ¥1.7bn |
| —segment total | revenue | 2021-09-01 → 2022-08-31 | ¥20.4bn |
| —segment total | revenue external | 2021-09-01 → 2022-08-31 | ¥20.4bn |
| —segment total | revenue intersegment | 2021-09-01 → 2022-08-31 | ¥2m |
| —segment total | segment profit | 2021-09-01 → 2022-08-31 | ¥6.2bn |
| Reconciling Itemsreconciling | revenue | 2020-09-01 → 2021-08-31 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-09-01 → 2021-08-31 | −¥1m |
| Dental Related Productsreportable segment | depreciation | 2020-09-01 → 2021-08-31 | ¥555m |
| Dental Related Productsreportable segment | revenue | 2020-09-01 → 2021-08-31 | ¥7.3bn |
| Dental Related Productsreportable segment | revenue external | 2020-09-01 → 2021-08-31 | ¥7.3bn |
| Dental Related Productsreportable segment | segment profit | 2020-09-01 → 2021-08-31 | ¥2.2bn |
| Eyeless Needle Related Productsreportable segment | depreciation | 2020-09-01 → 2021-08-31 | ¥577m |
| Eyeless Needle Related Productsreportable segment | revenue | 2020-09-01 → 2021-08-31 | ¥5.0bn |
| Eyeless Needle Related Productsreportable segment | revenue external | 2020-09-01 → 2021-08-31 | ¥5.0bn |
| Eyeless Needle Related Productsreportable segment | revenue intersegment | 2020-09-01 → 2021-08-31 | ¥1m |
| Eyeless Needle Related Productsreportable segment | segment profit | 2020-09-01 → 2021-08-31 | ¥1.5bn |
| Surgel Related Productsreportable segment | depreciation | 2020-09-01 → 2021-08-31 | ¥312m |
| Surgel Related Productsreportable segment | revenue | 2020-09-01 → 2021-08-31 | ¥4.9bn |
| Surgel Related Productsreportable segment | revenue external | 2020-09-01 → 2021-08-31 | ¥4.9bn |
| Surgel Related Productsreportable segment | segment profit | 2020-09-01 → 2021-08-31 | ¥1.6bn |
| —segment total | depreciation | 2020-09-01 → 2021-08-31 | ¥1.4bn |
| —segment total | revenue | 2020-09-01 → 2021-08-31 | ¥17.2bn |
| —segment total | revenue external | 2020-09-01 → 2021-08-31 | ¥17.2bn |
| —segment total | revenue intersegment | 2020-09-01 → 2021-08-31 | ¥1m |
| —segment total | segment profit | 2020-09-01 → 2021-08-31 | ¥5.3bn |
| Dental Related Productsreportable segment | employees | at 2022-08-31 | 100 pure |
| Eyeless Needle Related Productsreportable segment | employees | at 2022-08-31 | 75 pure |
| Surgel Related Productsreportable segment | employees | at 2022-08-31 | 68 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,510
| Item | Context | Value | Unit |
|---|---|---|---|
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E02340-000SurgelRelatedProductsReportableSegmentsMember | 312000000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E02340-000EyelessNeedleRelatedProductsReportableSegmentsMember | 577000000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E02340-000DentalRelatedProductsReportableSegmentsMember | 555000000 | JPY |
| Depreciation segment information | Prior1YearDuration_ReportableSegmentsMember | 1444000000 | JPY |
| Depreciation segment information | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Depreciation segment information | Prior1YearDuration | 1444000000 | JPY |
| Amortization of goodwill sga | Prior1YearDuration_jpcrp030000-asr_E02340-000SurgelRelatedProductsReportableSegmentsMember | － | JPY |
| Amortization of goodwill sga | Prior1YearDuration_jpcrp030000-asr_E02340-000EyelessNeedleRelatedProductsReportableSegmentsMember | － | JPY |
| Amortization of goodwill sga | Prior1YearDuration_jpcrp030000-asr_E02340-000DentalRelatedProductsReportableSegmentsMember | 97000000 | JPY |
| Amortization of goodwill sga | Prior1YearDuration_ReportableSegmentsMember | 97000000 | JPY |
| Amortization of goodwill sga | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Amortization of goodwill sga | Prior1YearDuration | 97000000 | JPY |
| Revenues from external customers | CurrentYearDuration_jpcrp030000-asr_E02340-000SurgelRelatedProductsReportableSegmentsMember | 5959000000 | JPY |
| Revenues from external customers | CurrentYearDuration_jpcrp030000-asr_E02340-000EyelessNeedleRelatedProductsReportableSegmentsMember | 6250000000 | JPY |
| Revenues from external customers | CurrentYearDuration_jpcrp030000-asr_E02340-000DentalRelatedProductsReportableSegmentsMember | 8206000000 | JPY |
| Revenues from external customers | CurrentYearDuration_ReportableSegmentsMember | 20416000000 | JPY |
| Revenues from external customers | CurrentYearDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYearDuration | 20416000000 | JPY |
| Transactions with other segments | CurrentYearDuration_jpcrp030000-asr_E02340-000SurgelRelatedProductsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_jpcrp030000-asr_E02340-000EyelessNeedleRelatedProductsReportableSegmentsMember | 2000000 | JPY |
| Transactions with other segments | CurrentYearDuration_jpcrp030000-asr_E02340-000DentalRelatedProductsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_ReportableSegmentsMember | 2000000 | JPY |
| Transactions with other segments | CurrentYearDuration_ReconcilingItemsMember | -2000000 | JPY |
| Transactions with other segments | CurrentYearDuration | － | JPY |
| Net sales | CurrentYearDuration_jpcrp030000-asr_E02340-000SurgelRelatedProductsReportableSegmentsMember | 5959000000 | JPY |
| Net sales | CurrentYearDuration_jpcrp030000-asr_E02340-000EyelessNeedleRelatedProductsReportableSegmentsMember | 6253000000 | JPY |
| Net sales | CurrentYearDuration_jpcrp030000-asr_E02340-000DentalRelatedProductsReportableSegmentsMember | 8206000000 | JPY |
| Net sales | CurrentYearDuration_ReportableSegmentsMember | 20419000000 | JPY |
| Net sales | CurrentYearDuration_ReconcilingItemsMember | -2000000 | JPY |
| Net sales | CurrentYearDuration | 20416000000 | JPY |
| Operating income | CurrentYearDuration_jpcrp030000-asr_E02340-000SurgelRelatedProductsReportableSegmentsMember | 1980000000 | JPY |
| Operating income | CurrentYearDuration_jpcrp030000-asr_E02340-000EyelessNeedleRelatedProductsReportableSegmentsMember | 1751000000 | JPY |
| Operating income | CurrentYearDuration_jpcrp030000-asr_E02340-000DentalRelatedProductsReportableSegmentsMember | 2430000000 | JPY |
| Operating income | CurrentYearDuration_ReportableSegmentsMember | 6163000000 | JPY |
| Operating income | CurrentYearDuration_ReconcilingItemsMember | － | JPY |
| Operating income | CurrentYearDuration | 6163000000 | JPY |
| Depreciation segment information | CurrentYearDuration_jpcrp030000-asr_E02340-000SurgelRelatedProductsReportableSegmentsMember | 356000000 | JPY |
| Depreciation segment information | CurrentYearDuration_jpcrp030000-asr_E02340-000EyelessNeedleRelatedProductsReportableSegmentsMember | 617000000 | JPY |
| Depreciation segment information | CurrentYearDuration_jpcrp030000-asr_E02340-000DentalRelatedProductsReportableSegmentsMember | 695000000 | JPY |
| Depreciation segment information | CurrentYearDuration_ReportableSegmentsMember | 1669000000 | JPY |
| Depreciation segment information | CurrentYearDuration_ReconcilingItemsMember | － | JPY |
| Depreciation segment information | CurrentYearDuration | 1669000000 | JPY |
| Amortization of goodwill sga | CurrentYearDuration_jpcrp030000-asr_E02340-000SurgelRelatedProductsReportableSegmentsMember | － | JPY |
| Amortization of goodwill sga | CurrentYearDuration_jpcrp030000-asr_E02340-000EyelessNeedleRelatedProductsReportableSegmentsMember | － | JPY |
| Amortization of goodwill sga | CurrentYearDuration_jpcrp030000-asr_E02340-000DentalRelatedProductsReportableSegmentsMember | 76000000 | JPY |
| Amortization of goodwill sga | CurrentYearDuration_ReportableSegmentsMember | 76000000 | JPY |
| Amortization of goodwill sga | CurrentYearDuration_ReconcilingItemsMember | － | JPY |
| Amortization of goodwill sga | CurrentYearDuration | 76000000 | JPY |
| Impairment loss el | CurrentYearDuration_jpcrp030000-asr_E02340-000SurgelRelatedProductsReportableSegmentsMember | － | JPY |
| Impairment loss el | CurrentYearDuration_jpcrp030000-asr_E02340-000EyelessNeedleRelatedProductsReportableSegmentsMember | 21000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |